At Bioverativ, a Sanofi company, we understand the importance of providing a reliable supply of high-quality medicines.
We are committed to ensuring that rigorous purity and quality standards are maintained during the manufacture of our products, and that patients have access to their medicines, whenever and wherever they need them.
To deliver on this responsibility, we have an exclusive manufacturing and supply agreement with Biogen, the company from which Bioverativ was formed and an organisation with world-class manufacturing expertise. Biogen has been successfully manufacturing complex biologic therapies for more than two decades and supplies medicines to patients in more than 80 countries.
Our products are manufactured at Biogen’s Research Triangle Park facility in North Carolina, a state-of-the-art manufacturing plant that uses cutting-edge technology. It is also one of the largest biologic manufacturing facilities of its kind in the world.
Our haemophilia products are manufactured in human cell lines, and no human or animal proteins are ever added. Our products also undergo testing during all stages of the manufacturing process to ensure they meet strict standards of quality.